| # | Title | Journal | Year | Citations |
|---|
|
| 1 | Leptin and renal disease | American Journal of Kidney Diseases | 2002 | 6,162 |
| 2 | Revised Equations for Estimated GFR From Serum Creatinine in Japan | American Journal of Kidney Diseases | 2009 | 5,415 |
| 3 | Clinical epidemiology of cardiovascular disease in chronic renal disease | American Journal of Kidney Diseases | 1998 | 3,028 |
| 4 | Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third national health and nutrition examination survey | American Journal of Kidney Diseases | 2003 | 2,218 |
| 5 | Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study | American Journal of Kidney Diseases | 1998 | 2,161 |
| 6 | Death Risk in Hemodialysis Patients: The Predictive Value of Commonly Measured Variables and an Evaluation of Death Rate Differences Between Facilities | American Journal of Kidney Diseases | 1990 | 1,880 |
| 7 | Hospital-acquired renal insufficiency | American Journal of Kidney Diseases | 2002 | 1,709 |
| 8 | Accuracy of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Diagnosis and Prognosis in Acute Kidney Injury: A Systematic Review and Meta-analysis | American Journal of Kidney Diseases | 2009 | 1,639 |
| 9 | Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis | American Journal of Kidney Diseases | 2002 | 1,455 |
| 10 | KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease | American Journal of Kidney Diseases | 2007 | 1,329 |
| 11 | KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD | American Journal of Kidney Diseases | 2014 | 1,319 |
| 12 | Preserving renal function in adults with hypertension and diabetes: A consensus approach | American Journal of Kidney Diseases | 2000 | 1,316 |
| 13 | 2002 annual report: ESRD clinical performance measures project | American Journal of Kidney Diseases | 2003 | 1,266 |
| 14 | KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update | American Journal of Kidney Diseases | 2020 | 1,239 |
| 15 | KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update | American Journal of Kidney Diseases | 2012 | 1,125 |
| 16 | Bone metabolism and disease in chronic kidney disease | American Journal of Kidney Diseases | 2003 | 1,108 |
| 17 | III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: Update 2000 | American Journal of Kidney Diseases | 2001 | 1,090 |
| 18 | Goodpasture syndrome during the course of a Schönlein-Henoch purpura | American Journal of Kidney Diseases | 2002 | 1,064 |
| 19 | Clinical Practice Guidelines for Vascular Access | American Journal of Kidney Diseases | 2006 | 1,022 |
| 20 | KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update | American Journal of Kidney Diseases | 2020 | 968 |
| 21 | Long-term Risk of Mortality and Other Adverse Outcomes After Acute Kidney Injury: A Systematic Review and Meta-analysis | American Journal of Kidney Diseases | 2009 | 959 |
| 22 | Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKD | American Journal of Kidney Diseases | 2008 | 954 |
| 23 | Tubulointerstitial Changes as a Major Determinant in the Progression of Renal Damage | American Journal of Kidney Diseases | 1992 | 940 |
| 24 | Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS) | American Journal of Kidney Diseases | 2008 | 912 |
| 25 | KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update | American Journal of Kidney Diseases | 2015 | 872 |
| 26 | Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease | American Journal of Kidney Diseases | 1998 | 863 |
| 27 | Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences | American Journal of Kidney Diseases | 2003 | 833 |
| 28 | Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and Better Risk Predictions | American Journal of Kidney Diseases | 2010 | 808 |
| 29 | C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients | American Journal of Kidney Diseases | 2000 | 798 |
| 30 | A Malnutrition-Inflammation Score is correlated with morbidity and mortality in maintenance hemodialysis patients | American Journal of Kidney Diseases | 2001 | 797 |
| 31 | Hypernatremia in the Critically Ill Is an Independent Risk Factor for Mortality | American Journal of Kidney Diseases | 2007 | 770 |
| 32 | Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin | American Journal of Kidney Diseases | 1999 | 759 |
| 33 | US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States | American Journal of Kidney Diseases | 2017 | 750 |
| 34 | Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patients | American Journal of Kidney Diseases | 1996 | 728 |
| 35 | US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States | American Journal of Kidney Diseases | 2019 | 722 |
| 36 | The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease | American Journal of Kidney Diseases | 1996 | 710 |
| 37 | End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions | American Journal of Kidney Diseases | 1999 | 707 |
| 38 | Use of Allopurinol in Slowing the Progression of Renal Disease Through Its Ability to Lower Serum Uric Acid Level | American Journal of Kidney Diseases | 2006 | 707 |
| 39 | Introduction: National Kidney Foundation 50th anniversary commemorative issue | American Journal of Kidney Diseases | 2000 | 693 |
| 40 | Antihypertensive Therapy in the Presence of Proteinuria | American Journal of Kidney Diseases | 2007 | 675 |
| 41 | Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate | American Journal of Kidney Diseases | 2002 | 673 |
| 42 | Pathologic classification of focal segmental glomerulosclerosis: a working proposal | American Journal of Kidney Diseases | 2004 | 672 |
| 43 | Clinical Practice Guidelines for Vascular Access | American Journal of Kidney Diseases | 2006 | 658 |
| 44 | KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target | American Journal of Kidney Diseases | 2007 | 647 |
| 45 | US Renal Data System 2011 Annual Data Report | American Journal of Kidney Diseases | 2012 | 643 |
| 46 | Hemodialysis Membrane With a High-Molecular-Weight Cutoff and Cytokine Levels in Sepsis Complicated by Acute Renal Failure: A Phase 1 Randomized Trial | American Journal of Kidney Diseases | 2007 | 639 |
| 47 | KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Acute Kidney Injury | American Journal of Kidney Diseases | 2013 | 629 |
| 48 | Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention | American Journal of Kidney Diseases | 1996 | 627 |
| 49 | Anemia management and outcomes from 12 countries in the dialysis outcomes and practice patterns study (DOPPS) | American Journal of Kidney Diseases | 2004 | 605 |
| 50 | US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States | American Journal of Kidney Diseases | 2018 | 605 |
